Methylphenidate and risk of serious cardiovascular events in adults

American Journal of Psychiatry

Volumn 169, Issue 2, 2012, Pages 178-185

  Schelleman, Hedi ^a,b,c,d   Bilker, Warren B ^a,b,c,d   Kimmel, Stephen E ^a,b,c,d   Daniel, Gregory W ^a,b,c,d   Newcomb, Craig ^a,b,c,d   Guevara, James P ^a,b,c,d   Cziraky, Mark J ^a,b,c,d   Strom, Brian L ^a,b,c,d   Hennessy, Sean ^a,b,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HEALTHCORE INC   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; ATOMOXETINE; METHYLPHENIDATE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG SAFETY; DRUG USE; FEMALE; HEALTH INSURANCE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; STROKE; SUDDEN DEATH; TREATMENT DURATION;

EID: 84857620191     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.11010125     Document Type: Article

References (27)

1. Nissen SE: ADHD drugs and cardiovascular risk. N Engl J Med 2006; 354:1445-1448
2. Adler LA, Spencer TJ, Milton DR, Moore RJ, Michelson D: Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. J Clin Psychiatry 2005; 66:294-299 (Pubitemid 40476751)
3. Weisler RH, Biederman J, Spencer TJ, Wilens TE: Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr 2005; 10(suppl 20):35-43 (Pubitemid 43010496)
4. Rosler M, Fischer R, Ammer R, Ose C, Retz W: A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 2009; 259:120-129
5. Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L; 304 Study Group: Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. CNS Spectr 2009; 14:573-585
6. Hennessy S, Schelleman H, Daniel GW, Bilker WB, Kimmel SE, Guevara J, Cziraky MJ, Strom BL: Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study. Pharmacoepidemiol Drug Saf 2010; 19:934-941
7. Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S: Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics 2011; 127:1102-1110
8. Hennessy S, Leonard CE, Palumbo CM, Newcomb C, Bilker WB: Quality of Medicaid and Medicare data obtained through Centers for Medicare and Medicaid Services (CMS). Med Care 2007; 45:1216-1220
9. Hennessy S, Leonard CE, Freeman CP, Deo R, Newcomb C, Kimmel SE, Strom BL, Bilker WB: Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf 2010; 19:555-562
10. Leibson CL, Naessens JM, Brown RD, Whisnant JP: Accuracy of hospital discharge abstracts for identifying stroke. Stroke 1994; 25:2348-2355 (Pubitemid 24359301)
11. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R: The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998; 29:415-421 (Pubitemid 28086685)
12. Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, Copper LS, Shahar E: Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1999; 30:736-743 (Pubitemid 29156360)
13. Williams GR, Jiang JG, Matchar DB, Samsa GP: Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke 1999; 30:2523-2528
14. Heckbert SR, Kooperberg C, Safford MM, Psaty BM, Hsia J, McTier nan A, Gaziano JM, Frishman WH, Curb JD: Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol 2004; 160:1152-1158 (Pubitemid 39628055)
15. Pladevall M, Goff DC, Nichaman MZ, Chan F, Ramsey D, Ortiz C, Labarthe DR: An assessment of the validity of ICD code 410 to identify hospital admissions for myocardial infarction: the Corpus Christi Heart Project. Int J Epidemiol 1996; 25:948-952 (Pubitemid 26348671)
16. Petersen LA, Wright S, Normand SL, Daley J: Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. J Gen Intern Med 1999; 14:555-558 (Pubitemid 29441635)
17. Tu JV, Naylor CD, Austin P: Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ 1999; 161:1257-1261
18. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH: Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004; 148:99-104 (Pubitemid 38900487)
19. Wahl PM, Terrell DR, George JN, Rodgers JK, Uhl L, Cataland S, Bohn RL: Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially insured population. Thromb Haemost 2010; 103:1203-1209
20. Heron M: Deaths: Leading Causes for 2006 (National Vital Statistics Reports, vol 58, no 14). Hyattsville, Md, National Center for Health Statistics, 2010
21. Cox DR: Regression models and life tables. J R Stat Soc Series B Stat Methodol 1972; 34:187-220
22. Huber PJ: The behavior of maximum likelihood estimation under nonstandard conditions, in Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, University of California Press, 1967, pp 221-233
23. White H: Maximum likelihood estimation of misspecified models. Econometrica 1982; 50:1-25
24. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55
25. Daly MW, Custer G, McLeay PD: Cardiac arrest with pulseless electrical activity associated with methylphenidate in an adolescent with a normal baseline echocardiogram. Pharmacotherapy 2008; 28:1408-1412
26. Holick CN, Turnbull BR, Jones ME, Chaudhry S, Bangs ME, Seeger JD: Atomoxetine and cerebrovascular outcomes in adults. J Clin Psychopharmacol 2009; 29:453-460
27. Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T: Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166:992-1001